Milagros González‐Rivera

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz et al. · Clinical Cancer Research · 2016 · 137 citations · Full text

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz et al. · Clinical Cancer Research · 2018 · 125 citations

<i>In Vitro</i> Acquisition of Secondary Azole Resistance in Aspergillus fumigatus Isolates after Prolonged Exposure to Itraconazole: Presence of Heteroresistant Populations

Pilar Escribano, Sandra Recio, Teresa Peláez et al. · Antimicrobial Agents and Chemotherapy · 2011 · 44 citations · Full text

Diagnostic Mycology, Aspergillus Fumigatus, Fungal Cell Biology +19

Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer

Miguel Martín, Milagros González‐Rivera, Serafín Morales et al. · Current Medical Research and Opinion · 2015 · 43 citations · Full text

Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial

Milagros González‐Rivera, Miriam Lobo, Sara López‐Tarruella et al. · Breast Cancer Research and Treatment · 2016 · 40 citations

Breast Oncology, Cancer Pathology, Unselected Prospective Cohort +10